Prominin-2 Suppresses Ferroptosis Sensitivity

Alexia Belavgeni1, Stefan R Bornstein2, Andreas Linkermann3

  • 1Division of Nephrology, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.

Developmental Cell
|December 4, 2019
PubMed

Insights

Ferroptosis, a cell death pathway, contributes to organ damage in heart attacks and kidney injury. Researchers identified prominin-2 as a new natural inhibitor of ferroptosis.

Area of Science:

  • Biomedical research
  • Cellular biology
  • Pathophysiology

Background:

  • Ferroptosis is an iron-dependent form of regulated cell death.
  • Ferroptosis contributes to tissue damage in conditions like myocardial infarction and acute kidney injury.
  • The endogenous regulators of ferroptosis are not fully understood.

Purpose of the Study:

  • To identify novel endogenous inhibitors of ferroptosis.
  • To investigate the role of specific cellular components in ferroptosis regulation.

Main Methods:

  • Utilized cell-based assays to screen for ferroptosis inhibitors.
  • Employed molecular biology techniques to identify and characterize novel regulatory proteins.
  • Investigated the function of prominin-2 in ferroptosis using genetic and biochemical approaches.

Main Results:

  • Identified the pentaspan membrane glycoprotein prominin-2 as a novel endogenous inhibitor of ferroptosis.
  • Demonstrated that prominin-2 can suppress ferroptosis in cellular models.
  • Provided evidence for a new mechanism regulating ferroptosis.

Conclusions:

  • Prominin-2 is a newly discovered endogenous inhibitor of ferroptosis.
  • Targeting prominin-2 may offer therapeutic strategies for conditions involving ferroptosis-mediated tissue damage, such as heart attacks and acute kidney injury.